Daniela Galliano
Overview
Explore the profile of Daniela Galliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cozzolino M, Cecchino G, Garcia Velasco J, Pellicer N, Galliano D, Pellicer A
Hum Reprod
. 2023 Jun;
38(8):1621-1627.
PMID: 37336546
Study Question: What is the potential impact of preimplantation genetic testing for aneuploidy (PGT-A) on obstetric and neonatal outcomes? Summary Answer: PGT-A is not associated with increased rates of adverse...
12.
Pellegrini L, de Angelis F, Tartaglia S, Toschi M, Galliano D, Pellicer A, et al.
Arch Gynecol Obstet
. 2023 Jun;
308(3):989-995.
PMID: 37318611
Purpose: The regulated transportation of cryopreserved human embryos resulting from assisted reproduction treatments offers opportunities for patients undergoing embryo transfer in other regions/countries. However, the principal concern for fertility clinics...
13.
Pellicer N, Cozzolino M, Diaz-Garcia C, Galliano D, Cobo A, Pellicer A, et al.
Reprod Biomed Online
. 2023 Jan;
46(3):543-565.
PMID: 36710157
The ovary has a comparatively short functional lifespan compared with other organs, and genetic and pathological injuries can further shorten its functional life. Thus, preserving ovarian function should be considered...
14.
Cozzolino M, Pellicer N, Galliano D, Pellicer A
Reprod Biomed Online
. 2022 Nov;
46(1):150-155.
PMID: 36402667
Research Question: Does aromatase inhibitor improve IVF outcomes by reducing local oestrogen production in patients with adenomyosis undergoing long-term gonadotrophin-releasing hormone agonist (GnRHa) treatment? Design: Four patients with severe adenomyosis...
15.
Bellver J, Marin C, Lathi R, Murugappan G, Labarta E, Vidal C, et al.
Reprod Sci
. 2021 May;
28(11):3171-3180.
PMID: 34033112
Our aim was to determine prospectively whether increased body mass index (BMI) affects endometrial receptivity through displacement of the window of implantation (dWOI) using the endometrial receptivity analysis (ERA), and...
16.
Pellicer N, Galliano D, Herraiz S, Bagger Y, Arce J, Pellicer A
Hum Reprod
. 2020 Dec;
36(4):850-858.
PMID: 33355352
Endometriosis requires medical management during a woman's reproductive years. Most treatments aim to create a hypoestrogenic milieu, but for patients wishing to conceive, drugs that allow normal ovarian function are...
17.
Requena A, Cruz M, Vergara V, Prados N, Galliano D, Pellicer A
Reprod Biomed Online
. 2020 May;
41(1):1-5.
PMID: 32451301
The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most...
18.
Alviggi C, Esteves S, Orvieto R, Conforti A, La Marca A, Fischer R, et al.
Reprod Biol Endocrinol
. 2020 May;
18(1):45.
PMID: 32404170
The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular....
19.
20.
Esteves S, Alviggi C, Humaidan P, Fischer R, Andersen C, Conforti A, et al.
Front Endocrinol (Lausanne)
. 2019 Dec;
10:814.
PMID: 31824427
This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary objective is to contextualize the Poseidon criteria and their metric of success...